Mechanisms Linking Uric Acid to Coronary Artery Calcification in Diabetic Kidney Disease

Overview

This review explores the relationship between uric acid and accelerated coronary artery calcification (CAC) in diabetic kidney disease (DKD).

Background

Coronary artery calcification is a significant predictor of cardiovascular morbidity and mortality, particularly in patients with diabetic kidney disease. Traditional risk factors do not fully account for the rapid progression of CAC in this population.

Data Highlights

Key Findings

• Coronary artery calcification progresses more rapidly in patients with diabetic kidney disease.
• Uric acid is associated with renal metabolic stress and inflammatory pathway activation in DKD.
• Uric acid may influence vascular smooth muscle cell behavior and endothelial function.
• Recent technologies like single-cell sequencing and spatial transcriptomics are being utilized to study UA-related cellular interactions.
• The review proposes a UA–kidney–immune–vascular framework to understand CAC progression in DKD.

Clinical Implications

Understanding the mechanisms linking uric acid to coronary artery calcification may help identify new therapeutic targets in diabetic kidney disease.

Conclusion

This review provides an overview of the potential mechanisms by which uric acid may contribute to accelerated coronary artery calcification in diabetic kidney disease.

Related Resources & Content

1. Frontiers | Uric Acid–Associated Mechanisms of Coronary Artery Calcification in Diabetic Kidney Disease: Evidence, Hypotheses, and Translational Perspectives
2. European Journal of Preventive Cardiology — Blood sugar to calcification: unveiling hyperglycaemia’s valvular risk
3. BMC Endocrine Disorders — The association between the triglyceride-glucose index and serum uric acid: a systematic review and meta-analysis
4. Frontiers in Cardiovascular Medicine — Predictive value of the uric acid-to-albumin ratio for contrast-induced nephropathy after percutaneous coronary intervention and construction of a clinical prediction model in patients with coronary artery disease
5. Frontiers in Endocrinology — Editorial: Cardiovascular risks in cardiovascular-kidney-metabolic syndrome: mechanisms and therapies
6. KDIGO 2024 CKD Guideline
7. 2026 ACC/AHA/AACVPR/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Dyslipidemia
8. Opportunistic Detection of Coronary Artery Calcium on Noncardiac Chest Computed Tomography
9. Chronic Kidney Disease and Risk Management: Standards of Care in Diabetes—2026
10. Association of hyperuricemia with coronary heart disease and other cardiovascular outcomes: A systematic review and dose-response meta-analysis | PLOS One
11. Uric Acid Levels and Cardiovascular and Cerebrovascular Diseases: A Mendelian Randomization Study - PubMed
12. Frontiers | Evaluation of febuxostat in treating diabetic kidney disease with hyperuricemia: a systematic review and meta-analysis of randomized controlled trials
13. Frontiers | Association between serum uric acid to high-density lipoprotein cholesterol ratio (UHR) and abdominal aortic calcification: a cross-sectional study based on NHANES 2013–2014
14. Vascular Calcification in Chronic Kidney Disease and Hemodialysis: Pathophysiological Mechanisms and Emerging Biomarkers - PMC
15. Frontiers | Uric Acid–Associated Mechanisms of Coronary Artery Calcification in Diabetic Kidney Disease: Evidence, Hypotheses, and Translational Perspectives
16. 2026 Guideline on the Management of Dyslipidemia - Professional Heart Daily | American Heart Association